Our previous methylation microarray study (GSE52068) analysed genome-wide DNA methylation between normal nasopharyngeal (n = 24) and NPC tumour (n = 24) samples24, from which we identified seven hypermethylated CpG sites in the promoter of USP44 (Fig. 1a). The gene discussed is USP44; the disease is neoplasm.